Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Hypoxia-inducible Factor 1 Alpha (HIF-1α) as a Prognostic Indicator in Patients with Gastric Tumors: A Meta-analysis

  • Zhang, Zhi-Gang (Evidence Based Medicine Center of Lanzhou University) ;
  • Zhang, Qiu-Ning (The First Clinical Medical College of Lanzhou University) ;
  • Wang, Xiao-Hu (Evidence Based Medicine Center of Lanzhou University) ;
  • Tian, Jin-Hui (Evidence Based Medicine Center of Lanzhou University)
  • Published : 2013.07.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background and Objective: Though researched for years, the prognostic role of hypoxia-inducible factor 1 alpha (HIF-$1{\alpha}$) in gastric cancer is still controversial. We thus undertook a systematic review to assess the relationship. Method: A systematically literature search of Pubmed, Embase, Web of Science, China Biological Medicine Disc and Cochrane Library was undertaken in February 2013, and the reference lists of articles were retrieved. Results: 12 trials (1,555 participants) were included to assess the association between HIF-$1{\alpha}$ expression and survival. Summary hazard ratios (HRs) were calculated. HIF-$1{\alpha}$ expression was significantly correlated with poor overall survival of gastric cancer patients (HR=1.34, 95%CI: 1.13-1.58; P=0.0009), but not with poor disease free survival of gastric cancer patients (HR=1.67, 95%CI: 0.99-2.82; P=0.06). Conclusion: HIF-$1{\alpha}$ was associated with poor OS, but not DFS, especially for Asian patients. But studies evaluating relationships of HIF-$1{\alpha}$ with OS and DFS in non-Asian gastric cancer patients appear needed.

Keywords

References

  1. Bertuccio P, Chatenoud L, Levi F, et al (2009). Recent patterns in gastric cancer: a global overview. Int J Cancer, 125, 666-73. https://doi.org/10.1002/ijc.24290
  2. Griffiths EA, Pritchard SA, Valentine HR, et al (2007). Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer, 96, 95-103. https://doi.org/10.1038/sj.bjc.6603524
  3. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
  4. Isobe T, Aoyagi K, Koufuji K, et al (2013). Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1alpha) expression in gastric cancer. Int J Clin Oncol, 18, 293-304. https://doi.org/10.1007/s10147-012-0378-8
  5. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  6. Kolev Y, Uetake H, Takagi Y, Sugihara K (2008). Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol, 15, 2336-44. https://doi.org/10.1245/s10434-008-9955-5
  7. Liu L, Ma XL, Xiao ZL, et al (2012). Prognostic value of vascular endothelial growth factor expression in resected gastric cancer. Asian Pac J Cancer Prev, 13, 3089-97. https://doi.org/10.7314/APJCP.2012.13.7.3089
  8. Nakamura J, Kitajima Y, Kai K, et al (2010). HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. Int J Cancer, 127, 1158-71.
  9. Oh SY, Kwon HC, Kim SH, et al (2008). Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer. BMC Cancer, 8, 123. https://doi.org/10.1186/1471-2407-8-123
  10. Qiu MZ, Han B, Luo HY, et al (2011). Expressions of hypoxia-inducible factor-1alpha and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features. Tumour Biol, 32, 159-66. https://doi.org/10.1007/s13277-010-0109-6
  11. Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32. https://doi.org/10.1038/nrc1187
  12. Shen CL, Shen ZB, Chen WD (2010). Expressions of VEGF, HIF-1 in gastric cancer and their impact on prognosis. Chin Gen Prac, 13, 2460-6.
  13. Stoeltzing O, McCarty MF, Wey JS, et al (2004). Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst, 96, 946-56. https://doi.org/10.1093/jnci/djh168
  14. Sumiyoshi Y, Kakeji Y, Egashira A, et al (2006). Overexpression of hypoxia-inducible factor $1{\alpha}$ and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res, 12, 5112-7. https://doi.org/10.1158/1078-0432.CCR-05-2382
  15. Takahashi R, Tanaka S, Hiyama T, et al (2003). Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep, 10, 797-802.
  16. Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8, 16. https://doi.org/10.1186/1745-6215-8-16
  17. Urano N, Fujiwara Y, Doki Y, et al (2006). Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer, 9, 44-9. https://doi.org/10.1007/s10120-005-0356-1
  18. Vermeulen PB, Gasparini G, Fox SB, et al (1996). Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer, 32A, 2474-84.
  19. Yang ZR, Wu Q, Li DW, Chen JW (2007). Expression and clinical significance of Notch1 and HIF-$1{\alpha}$ proteins in human gastric carcinoma. J Shanxi Med Univ, 38, 498-502.
  20. Yeo EJ, Chun YS, Cho YS, et al (2003). YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst, 95, 516-25. https://doi.org/10.1093/jnci/95.7.516
  21. Zhong H, De Marzo AM, Laughner E, et al (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 59, 5830-5.
  22. Zhou LH, Li LH, G L (2009). Expressions of TP and HIF-$1{\alpha}$ in gastric carcinoma tissues and their correlations with prognosis. Chin J Cance R Prev Treat, 16, 1315-9.

Cited by

  1. Influence of Ionizing Radiation on Ovarian Carcinoma SKOV-3 Xenografts in Nude Mice under Hypoxic Conditions vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2353
  2. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis vol.35, pp.5, 2014, https://doi.org/10.1007/s13277-013-1579-0
  3. Clinical impact of the Warburg effect in gastrointestinal cancer (Review) vol.45, pp.4, 2014, https://doi.org/10.3892/ijo.2014.2563
  4. HIF-1 Alpha Overexpression Correlates with Poor Overall Survival and Disease-Free Survival in Gastric Cancer Patients Post-Gastrectomy vol.9, pp.3, 2014, https://doi.org/10.1371/journal.pone.0090678
  5. Clinical and Prognostic Significance of HIF-1α, PTEN, CD44v6, and Survivin for Gastric Cancer: A Meta-Analysis vol.9, pp.3, 2014, https://doi.org/10.1371/journal.pone.0091842
  6. Altered Expression of Hypoxia-Inducible Factor-1α (HIF-1α) and Its Regulatory Genes in Gastric Cancer Tissues vol.9, pp.6, 2014, https://doi.org/10.1371/journal.pone.0099835
  7. Significance of Tissue Expression and Serum Levels of Angiopoietin-like Protein 4 in Breast Cancer Progression: Link to NF-κB /P65 Activity and Pro-Inflammatory Cytokines vol.16, pp.18, 2015, https://doi.org/10.7314/APJCP.2015.16.18.8579
  8. Prognosis value of Hypoxia-inducible factor-1α expression in patients with bone and soft tissue sarcoma: a meta-analysis vol.5, pp.1, 2016, https://doi.org/10.1186/s40064-016-3064-x
  9. An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids vol.14, pp.10, 2018, https://doi.org/10.1371/journal.pcbi.1006469
  10. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer vol.24, pp.22, 2018, https://doi.org/10.3748/wjg.v24.i22.2381
  11. Challenges facing antiangiogenesis therapy: The significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies vol.234, pp.5, 2018, https://doi.org/10.1002/jcp.27414
  12. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis vol.14, pp.1, 2019, https://doi.org/10.1186/s13018-019-1101-5